Remdesivir production to double from May, Home Ministry asks states to ensure smooth transport, supply and allocation

Union Home Secretary Ajay Bhalla, in a letter to chief secretaries of all states and Union territories (UTs), informes that an interim allocation and supply of the life-saving injection to the states/UTs has been scheduled from April 21 to April 30.

"In view of the above, I would urge you to issue necessary instructions to all the authorities concerned to take all measures for compliance with the above allocation and subsequent allocations to be made by MoHFW and DOP in a smooth and timely manner to ensure seamless supply and transport of Remdesivir to States/UTs concerned," he said.

In order to monitor and coordinate the supply of COVID-19 drugs on a daily basis, a mechanism has been set up under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers through the National Pharmaceuticals Pricing Authority (NPPA) and the Drugs Controller General of India, he further said.

"The supply of Remdesivir injection and imported drug Toclizumab is under severe constraint due to sharp increase in demand. Several steps have been taken to augment the production capacity of the seven licensed manufacturers of Remdesivir injection in the country from 38.80 lakh units per month to 74 lakh units per month by early May 2021," the letter said.

Emphasising the importance of the availability of the drug, Bhall stated that any disruption or hindrance to the movement of this drug, may have an unintended adverse effect to the nation's fight against COVID-19.

"I would also request you to personally monitor the supply of essential medicines required under COVID Treatment Protocol in your UT and appoint Nodal Officers who will be responsible for un-restricted and timely movement of Remdesivir within their UT as per allocation made by MoHFW," he added.